KSRBF yields 3.00% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, KSRBF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KSRBF + PFE for your $10,000?
Kossan Rubber Industries Bhd, an investment holding company, manufactures and sells latex disposable gloves in Malaysia and internationally. It operates through four segments: Technical Rubber Products, Gloves, Cleanroom Products, and Others. The company offers engineered rubber products, including marine dock fenders, high damping rubber bearings, elastomeric bearings, expansion joints, panels and liners, and mechanical pot bearings, as well as floating slab track bearings, lateral bearings, and rubber wedges; EVA products primarily for the shoe industries; and custom extruded products and profiles, such as pressure sensor, solid and sponge, extruded, structural insulation, and insulator profiles for domestic, construction and civil engineering, electrical appliance, industrial, and automotive applications. It also provides molded rubber products for automotive, pipe seals and gaskets, and industrial/general applications; rubber rolls for printing, transferring, laminating, coating, coiling, beading creasing, pressure, slitting, winding, and other applications; and polyurethane (PU) products, such as PU rollers, precision PU articles, and PU tubing sleeves and robs. In addition, it manufactures natural rubber latex and nitrile gloves, as well as rubber latex surgical and procedure gloves for healthcare, specialty, and cleanroom applications under Puresafe, Chemax, and 7th Sense brand names. Further, the company offers cleanroom facemasks, gloves, and wipes; and industrial personal protective equipment. Additionally, it engages in the fabrication and installation of machinery; manufacturing, processing, and trading of chemicals and rubber compounds; and distribution and property holding activities. The company was incorporated in 1979 and is based in Klang, Malaysia.
Full KSRBF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.